MIRA MIRA Pharmaceuticals Year-over-year earnings per share growth for the last twelve months

Brandmark of MIRA Pharma (MIRA)

MIRA Pharmaceuticals is overcoming stringent FDA and DEA oversight through protective patents. The quarterly EPS trend illustrates how the scientific alliance with cannabinoid research laboratories impacts financial stability, with the metric currently at 68.70. Looking ahead, the specialized R&D pipeline will ensure the release of breakthrough antidepressants without side effects.

MIRA Pharmaceuticals, Inc. (MIRA) - Year-over-year net earnings per share change for the last twelve months from 02/21/2024 to 11/17/2026

MIRA (MIRA Pharmaceuticals Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
Summary company analytics:MIRA Pharmaceuticals
Flagship merchandise of MIRA Pharmaceuticals, Inc.

This indicator measures the dynamics of net earnings per share compared to the same period last year, determining the real efficiency of the business capitalization. The stability of this trend confirms the resilience of MIRA Pharmaceuticals in developing safe non-opioid alternatives, while the quarterly EPS growth allows investors to distinguish fundamental value growth from short-term market fluctuations.

Competing companies

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Anebulo Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months InterCure|NTRB: Quarterly EPS earnings growth|NSRX - Year-over-year net earnings per share change for the last twelve months|IGC (IGC Pharma Inc) - Quarterly EPS earnings growth|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)